Kailera Therapeutics

?? Happy Employee Appreciation Day! ?? At Kailera, our bold, mission-driven team is the heart of everything we do. With an entrepreneurial spirit and a deep commitment to collaboration, we are working together to develop therapies that empower people to transform their lives and elevate their health. Today, we celebrate our incredible Kai Crew—whose dedication and passion drive our mission forward. Thank you for all that you do! #EmployeeAppreciationDay #KaiCrew #KaileraTx

Today on ?????????? ?????????????? ??????, we stand in support of this year’s theme: ???????????????? ??????????????, ?????????????????? ??????????. Obesity is complex, influenced by systemic factors, and we believe that meaningful change starts with placing people at the center.? ?? At Kailera Therapeutics, we are committed to developing next-generation therapies that empower individuals to take control of their health. Together—with healthcare professionals, policymakers, and communities—we can transform systems and create a healthier future for all. Learn more and get involved: https://lnkd.in/eS38U52? ?? ?#WorldObesityDay #WOD2025 #KaileraTx?

At Kailera Therapeutics, we are deeply committed?to our mission of developing therapies for obesity and related conditions that give people the power to transform their lives and elevate their overall health. ? As we continue to grow, we’re looking for passionate professionals to join our dynamic and diverse team. If you're driven to make a meaningful impact, we invite you to explore our career opportunities! ? Learn more: kailera.com/careers #hiring #biotechjobs #biotechnology #careers

Did you know that 1 billion people live with obesity today and this number is expected to double in the next 10 years? Ahead of World Obesity Day (March 4), check out the WOD fact sheet to learn more about how #obesity affects us all: https://bit.ly/4hK4Tcd ? #WorldObesityDay #WOD2025 #KaileraTx?/ World Obesity Federation

Last week, we gathered (virtually and in person) for our very first “Kai-nections!” Kai-nections is a monthly opportunity to get to know the Kai Crew while learning more about what’s happening across the business. A huge thank you to Alissa Fernald, Program Leader, for kicking off this new Kailera tradition by sharing more about our pipeline and programs! #Kainections #KaiCrew #KaileraTx

Kailera has recently been impacted by recruitment fraud attempts. To help ensure current and future candidates stay informed and protected, we are sharing our recruitment fraud statement below. We hope this helps our network recognize and avoid potential scams. Thank you for your attention to this matter! ? ?????????????? ?????????????????????? ?????????? ?????????????????? Job applicants should be aware of online job recruitment, interview, and offer scams. Kailera will only send email communications to job applicants/candidates from “@kailera.com” email addresses. ? If you have received a communication from someone claiming to represent Kailera and you suspect for any reason the communications may be fraudulent, please: (1) stop all communications with that individual immediately and do not share any personal information about yourself or anyone else; and (2) contact [email protected]?to verify if the communication is authentic. ?

We’re thrilled to welcome Jamie Coleman to the Kailera Therapeutics team as Chief Commercial Officer! Jamie is an accomplished commercial leader with nearly 25 years of experience across product lifecycle and therapeutic areas leading transformative brands, including Zepbound?. Jamie’s expertise in building and leading high-performing teams will be instrumental in helping us achieve our goal of delivering next-generation therapies for the treatment of obesity and related conditions. Learn more:?https://lnkd.in/gxQdcKc3 Welcome to the Kai Crew, Jamie! ? #KaiCrew #KaileraTx

The Kailera team had a fantastic week at #JPM25! We're excited to build on the momentum from this week as we advance our pipeline of next-generation chronic weight management therapies and drive forward our mission to empower people to transform their lives and elevate their overall health. #JPMHC25 #KaiCrew #KaileraTx / Kailera Therapeutics

We’re excited to share positive topline data from our partner Hengrui Pharma Co.,Ltd’s Phase 2 #obesity trial of GLP-1/GIP receptor dual agonist HRS9531 (being developed globally/ex-Greater China as KAI-9531). With over 22% mean weight loss at week 36 at the 8 mg dose and a favorable safety profile, these data support KAI-9531’s potential as a best-in-class treatment for obesity. Learn more here: https://lnkd.in/eTtDrfxK #KaileraTx ?#chronicweightmanagement

Kick off #JPM25 with us at the 1st Annual Sachs Associates #Sachs_BOIF Biopharma Obesity Innovation Forum! Our CEO Ron Renaud will participate in the Unmet Needs & NextGen Therapeutics Panel chaired by Annabel Samimy on Saturday, January 11. We're looking forward to a great panel discussion focused on advancing innovative, differentiated therapies for the treatment of #obesity and related conditions! Learn more: www.sachsforum.com/1boif #JPMweek #JPM2025